Liesveld J L, Rosell K, Panoskaltsis N, Belanger T, Harbol A, Abboud C N
Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
J Hematother Stem Cell Res. 2001 Oct;10(5):643-55. doi: 10.1089/152581601753193850.
Ultrastructural studies of marrow and examination of the in vivo processes of stem cell homing and mobilization show that multipotential hematopoietic progenitors are able to traverse endothelial cells. The regulation of this process by various classes of chemokines was studied in this report, using an in vitro model of transendothelial migration. Human umbilical vein endothelial cells (HUVECs) or bone marrow-derived endothelial cells (BMECs) were grown to confluence on 3-microm microporous membrane inserts and placed in 24-well culture plates. CD34(+) cells isolated from normal volunteer donor marrow by immunoadsorption or magnetic bead selection techniques were added to the inserts and various individual chemokines were added to the lower chamber of the culture plates in serum-free conditions. After 24 h, the percentage of transmigrated cells was determined. A mean of 8.5% of unfractionated marrow CD34(+) populations migrated, and all chemokines tested, with the exception of macrophage inflammatory protein-1alpha (MIP-1alpha), had some positive effect on this migration. The greatest effects were seen with stroma-derived factor-1alpha (SDF-1alpha) and stroma-derived factor-1beta (SDF-1beta), with lesser effects noted for other chemokines and cytokines. When the CD34(+) population was subselected for expression of CD38, a greater fraction of the CD38(-) cells migrated as compared to the CD38(+) fraction. CD34(+) cells isolated from mobilized peripheral blood and cord blood also migrated in response to chemokines. Chemokines of the CC, CXC, and CX(3)C classes as well as other hematopoietic cytokines may modulate the process of stem cell transmigration of endothelial cells. Further understanding of this process may help elucidate the mechanism of stem cell mobilization and homing.
对骨髓的超微结构研究以及对干细胞归巢和动员的体内过程的检查表明,多能造血祖细胞能够穿过内皮细胞。本报告使用跨内皮迁移的体外模型研究了各类趋化因子对这一过程的调节作用。人脐静脉内皮细胞(HUVECs)或骨髓来源的内皮细胞(BMECs)在3微米微孔膜插入物上生长至汇合,然后置于24孔培养板中。通过免疫吸附或磁珠选择技术从正常志愿者供体骨髓中分离出的CD34(+)细胞被添加到插入物中,并且在无血清条件下将各种单独的趋化因子添加到培养板的下室中。24小时后,测定迁移细胞的百分比。未分级的骨髓CD34(+)群体平均有8.5%发生迁移,除巨噬细胞炎性蛋白-1α(MIP-1α)外,所有测试的趋化因子对这种迁移都有一定的积极作用。基质衍生因子-1α(SDF-1α)和基质衍生因子-1β(SDF-1β)的作用最为显著,其他趋化因子和细胞因子的作用较小。当根据CD38的表达对CD34(+)群体进行亚选时,与CD38(+)部分相比,CD38(-)细胞迁移的比例更高。从动员的外周血和脐带血中分离出的CD34(+)细胞也对趋化因子产生迁移反应。CC、CXC和CX(3)C类趋化因子以及其他造血细胞因子可能调节干细胞穿过内皮细胞的过程。对这一过程的进一步了解可能有助于阐明干细胞动员和归巢的机制。